Publications by authors named "Matias Valsecchi"

Claim this Profile
E
Evaluation of Anti-Angiogenic Therapy Combined with Immunotherapy and Chemotherapy as a Strategy to Treat Locally Advanced and Metastatic Non-Small-Cell Lung Cancer.
Mahmoud Abdallah, Rick Voland, Malcolm Decamp, John Flickinger, Toni Pacioles, Matias Valsecchi

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision therapeutic targeting of human cancer cell motility.
Li Xu, Ryan Gordon, Rebecca Farmer, Abhinandan Pattanayak, Andrew Binkowski, Matias Valsecchi

Nat Commun· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the Current Role of Immunotherapy for Colon Cancer?
Fernando Galanternik, Gonzalo Recondo, Matías E Valsecchi, Martín Greco, Gonzalo Recondo

Rev Recent Clin Trials· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for Non-Small Cell Lung Cancer - Finally a Hint of Hope.
Gonzalo Recondo, Gonzalo Recondo, Fernando Galanternik, Martín Greco, Máximo de la Vega, Matías E Valsecchi

Rev Recent Clin Trials· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Marlana Orloff, Ryan Weight, Matias E Valsecchi, Takami Sato

Rev Recent Clin Trials· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Matias E Valsecchi, Marlana Orloff, Rino Sato, Inna Chervoneva, Carol L Shields

Ophthalmology· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer.
Matias E Valsecchi, Gerrit Kimmey, Arvinder Bir, Damian Silbermins

Rev Recent Clin Trials· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Breast Cancer Clinical Trials--The Era of the Surrogates.
Matias E Valsecchi

Rev Recent Clin Trials· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Matias E Valsecchi, Enrique Díaz-Cantón

Rev Recent Clin Trials· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Hormonal Therapies for Premenopausal Patients--What did we Learn from the TEXT/SOFT Trials?
Matías E Valsecchi, Gonzalo Recondo, Máximo de la Vega, Martín Greco, Gonzalo Recondo

Rev Recent Clin Trials· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successes and setbacks of early investigational drugs for melanoma.
Marlana Orloff, Matias E Valsecchi, Takami Sato

Expert Opin Investig Drugs· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
Matias E Valsecchi

N Engl J Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.
Matias E Valsecchi, Mizue Terai, David J Eschelman, Carin F Gonsalves, Inna Chervoneva

J Vasc Interv Radiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions.
Gonzalo Recondo, Enrique Dìaz Canton, Màximo de la Vega, Martin Greco, Gonzalo Recondo, Matias E Valsecchi

World J Clin Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances and new perspectives in the treatment of metastatic colon cancer.
Gonzalo Recondo, Enrique Díaz-Cantón, Máximo de la Vega, Martin Greco, Gonzalo Recondo, Matias E Valsecchi

World J Gastrointest Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent treatment advances and novel therapies in pancreas cancer: a review.
Matias E Valsecchi, Enrique Díaz-Cantón, Máximo de la Vega, Susan J Littman

J Gastrointest Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy for rectal cancer.
Matias E Valsecchi

Lancet Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of sunitinib targeting melanomas.
Matias E Valsecchi, Takami Sato

Expert Opin Investig Drugs· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome?
Ubaldo E Martinez-Outschoorn, Diana Whitaker-Menezes, Matias Valsecchi, Maria P Martinez-Cantarin, Alina Dulau-Florea

Semin Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma.
Matias E Valsecchi, Misti Coronel, Charles M Intenzo, Sung M Kim, Agnieszka K Witkiewicz

Melanoma Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.
Sandra L Wong, Charles M Balch, Patricia Hurley, Sanjiv S Agarwala, Timothy J Akhurst, Matias E Valsecchi

Ann Surg Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer.
Agnieszka K Witkiewicz, Adam Ertel, Jeanne McFalls, Matias E Valsecchi, Gordon Schwartz

Clin Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.
Sandra L Wong, Charles M Balch, Patricia Hurley, Sanjiv S Agarwala, Timothy J Akhurst, Matias E Valsecchi

J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Matias E Valsecchi, Mary McDonald, Jonathan R Brody, Terry Hyslop, Boris Freydin

Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
Matias E Valsecchi, Thomas Holdbrook, Benjamin E Leiby, Edward Pequignot, Susan J Littman

BMC Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis